SAMSRITA LABS LIMITED (SAMSRITA.BO)
INR 24.14
(0.0%)
INR 24.14
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.62 Million INR | 62.92% |
| 2022 | -7.07 Million INR | -147.55% |
| 2021 | 14.87 Million INR | 292.66% |
| 2020 | -7.71 Million INR | 61.04% |
| 2019 | -19.81 Million INR | 14.88% |
| 2018 | -23.27 Million INR | -124.79% |
| 2017 | -10.35 Million INR | -25.25% |
| 2016 | -8.26 Million INR | -5824.69% |
| 2015 | 144.43 Thousand INR | -46.96% |
| 2014 | 272.3 Thousand INR | -59.27% |
| 2013 | 668.51 Thousand INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -872 Thousand INR | -6.02% |
| 2023 Q4 | -822.45 Thousand INR | -80.76% |
| 2023 Q1 | -861 Thousand INR | 86.79% |
| 2023 Q2 | -485 Thousand INR | 43.67% |
| 2023 Q3 | -455 Thousand INR | 6.19% |
| 2023 FY | -2.62 Million INR | 62.92% |
| 2022 Q1 | -443 Thousand INR | -102.81% |
| 2022 Q4 | -6.52 Million INR | -7225.84% |
| 2022 Q2 | 3000.00 INR | 100.68% |
| 2022 FY | -7.07 Million INR | -147.55% |
| 2022 Q3 | -89 Thousand INR | -3066.67% |
| 2021 Q1 | -441 Thousand INR | 0.0% |
| 2021 FY | 14.87 Million INR | 292.66% |
| 2021 Q4 | 15.78 Million INR | 9553.29% |
| 2021 Q3 | -167 Thousand INR | 21.6% |
| 2021 Q2 | -213 Thousand INR | 51.7% |
| 2020 FY | -7.71 Million INR | 61.04% |
| 2019 FY | -19.81 Million INR | 14.88% |
| 2018 FY | -23.27 Million INR | -124.79% |
| 2017 FY | -10.35 Million INR | -25.25% |
| 2016 FY | -8.26 Million INR | -5824.69% |
| 2015 FY | 144.43 Thousand INR | -46.96% |
| 2014 FY | 272.3 Thousand INR | -59.27% |
| 2013 FY | 668.51 Thousand INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 2.76 Million INR | 194.879% |
| Biocon Limited | 10.22 Billion INR | 100.026% |
| Blue Jet Healthcare Limited | 1.63 Billion INR | 100.16% |
| Concord Biotech Limited | 3.08 Billion INR | 100.085% |
| Dishman Carbogen Amcis Limited | -1.53 Billion INR | 99.829% |
| FERMENTA BIOTECH LIMITED | -230.59 Million INR | 98.863% |
| GENOMIC VALLEY BIOTECH LIMITED | 151.81 Thousand INR | 1827.364% |
| Lyka Labs Limited | -24.89 Million INR | 89.466% |
| Panacea Biotec Limited | -11.73 Million INR | 77.643% |
| Servoteach Industries Limited | -2.37 Million INR | -10.465% |
| SMS Lifesciences India Limited | 90.92 Million INR | 102.884% |
| Supriya Lifescience Limited | 1.19 Billion INR | 100.22% |
| Syngene International Limited | 5.1 Billion INR | 100.051% |
| TAKE Solutions Limited | -1.19 Billion INR | 99.781% |
| Titan Biotech Limited | 248.53 Million INR | 101.055% |
| Transgene Biotek Limited | -6.55 Million INR | 59.993% |
| Vanta Bioscience Limited | -23.15 Million INR | 88.676% |